Work

Supplementary Data from A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy

Year: 2023

Type: supplementary-materials

Abstract: Suppl Fig. 1 lists the primer sequences for NFE2L2 and downstream gene targets of Nrf2. Suppl Fig. 2 shows that MSU38225 does not alter the overall expression pattern of abundant cellular proteins. Suppl Fig. 3 shows that MSU38225 does not inhibit the proliferation of MCF10A cells at concentrations that inhibit the Nrf2 pathway.

DOI: 10.1158/1535-7163.22523014.v1

Authors: Di Zhang, Zhilin Hou, Kelly E. Aldrich, Lizbeth Lockwood, Aaron L. Odom, Karen T. Liby

Language: English

Topic: Genomics, phytochemicals, and oxidative stress

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362487682

Cites:

Cited by:

Related to: 10